Table 4.
Histopathological blind grading findings of each group.
Groups | Histopathological Blind Grading Mean ± standard deviation (min–max) |
||||
---|---|---|---|---|---|
Cytoplasmic vacuolization | Cellular degeneration | Dilatation | Apoptotic cell | Nerve degeneration | |
Control group | 0.25 ± 0.46 (0–1) | 0.13 ± 0.36 (0–1) | 0.13 ± 0.36 (0–1) | 0.63 ± 0.52 (0–1) | 0.25 ± 0.46 (0–1) |
Sham group | 0.38 ± 0.52 (0–1) | 0 | 0.25 ± 0.46 (0–1) | 0.50 ± 0.53 (0–1) | 0.25 ± 0.46 (0–1) |
Whortleberry control group | 0.75 ± 0.71 (0–2) | 0.88 ± 0.99 (0–2) | 0.75 ± 0.89 (0–2) | 0.50 ± 0.53 (0–1) | 0.38 ± 0.52 (0–1) |
Cisplatin group | 3.63 ± 0.52 (3–4) | 3.13 ± 0.35 (3–4) | 2.63 ± 0.74 (2–4) | 3.00 ± 0.00 (3–3) | 2.50 ± 0.53 (2–3) |
Cisplatin + 100 mg/kg whortleberry group | 1.75 ± 0.46 (1–2) | 1.63 ± 0.52 (1–2) | 1.75 ± 0.46 (1–2) | 2.75 ± 0.46 (2–3) | 2.13 ± 0.83 (1–3) |
Cisplatin + 200 mg/kg whortleberry group | 0.88 ± 0.64 (0–2) | 0.88 ± 0.83 (0–2) | 0.50 ± 0.53 (0–1) | 1.00 ± 0.76 (0–2) | 1.50 ± 0.76 (0–2) |